Member Info for HarChris

Personally think it's poor form to accuse Vallance of acting in the interests of his stock portfolio rather than public health but if he actually has been he's failed to have much impact - GSK have fallen 25% in the last year.

And who is to say that those shares haven't already been sold, either on vaccine news or at some point on the way back up? Lazy speculation with no other intention but to disrupt the board today.

In answer to your question Bluelight, no we haven't been given a set date.

A la mode or not I assume by 'specific antivirals' he isn't talking about us seeing as we are seen as 'broad spectrum antivirals'

Porky I think we more or less agree, the only difference is I think that relationships like we have with the DHSC are key to unlocking that higher p/e, for the market to be confident that we are profit making long into the future...

I'm not convinced you can blame the MMs for the big share price movements. One was a huge sell off due to vaccine news and the other was a sustained period of buying pressure thanks to the second DHSC contract.

Don't agree with you there. Are you suggesting these holders will have waited months and months only to bail the moment they break even? They are big players that can handle selling at a loss, if they're still in it's because they see no reason to sell at this level.

The one thing I do disagree with you on Porky is the importance of the DHSC. Rolling out the Qs across the UK and playing a leading role in the decentralisation of testing here in the UK (and then hopefully abroad) is pivotal, as are further contracts with the government. Selling tests through distributors, however many countries and contacts we have, isn't likely to build this company into a multibillion pound one.

Fortunately there is nothing to suggest the relationship with the government is likely to be severed anytime soon.

He still thinks if we hit £50 a share we're worth twice pfizer.

No need to be so ****y Parsley - especially as you still don't understand how to calculate an mcap ;)

I think a couple of TR1s showing IIs loading up could push this well past placing price...

It's not going to hit broker targets without successful p3 results but the slow and steady recovery from 75p to 170p is thanks to the mounting body of scientific evidence which is building out the investment case for synairgen. No reason that won't continue all the way into the mis 2s and maybe as high as mid 3s with a little helping hand from our friend Activ 2.

I've been here quite a while now and I've never seen any definitive evidence of a pre-news leak.

From the 25 recommends I'm clearly not the only one that found your honesty refreshing - far less of that usually on here and far more chest-thumping and bragging. I truly hope we fly past £4.40 and you get to see profit!

Thanks Org, BetterLife appears to be much more of a competitor to synairgen than bamlanivimab.
If they are the biggest threat, for now at least, we should be resting easy.

That is not what Zwart was saying whatsoever! Ha

I imagine it's not just Eva's lack of humility that frustrates a few on here but her steadfast belief that she is a masterful investor when it's blindingly obvious to everyone else that she doesn't really know what she's doing.

Sold elsewhere and bought another chunk here for the absolutely, without doubt, last time. Exciting weeks ahead!

Do you think Topshop may be targeted to please the City - as an attempt to pump the share price towards the £6 figure to unlock the huge board bonuses? Is that at all plausible?

I'm sure Eva is doubling, trebling, and quadrupling down on Arb. It only takes one investment like that to go against you and you're completely out of pocket.